Daratumumab for injection is used for the treatment of patients with multiple myeloma (bone marrow cancer).

Daratumumab (trade name Darzalex) is an anti-cancer drug. It binds to CD38, which multiple myeloma cells overexpress.
In November 2015, the U.S. Food and Drug Administration (FDA) approved daratumumab for treatment of multiple myeloma in patients who had received at least three prior therapies. In May 2016 daratumumab was also conditionally approved by the European Medicines Agency for treatment of multiple myeloma.
In November 2016, the FDA approved daratumumab in combination with lenalidomide or bortezomib and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
In May 2018, the FDA expanded the approval of daratumumab for use in combination with bortezomib, melphalan and prednisone to include the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.

daratumumab for injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of daratumumab for injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the daratumumab for injection medicine cost price in India.

The order for daratumumab for injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

DARZALEX (daratumumab) injection, for intravenous use. Initial U.S. Approval – 2015

Generic Name: daratumumab

Injection: • 100 mg/5 mL solution in a single-dose vial
• 400 mg/20 mL solution in a single-dose vial

Daratumumab

Get In Touch

DARZALEX (daratumumab) for injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand DARZALEX (daratumumab) for injection on prescription and Import License in Patient's Name only.

For overseas patients, DARZALEX (daratumumab) for injection can be made available in Send your enquiry to find DARZALEX (daratumumab) for injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for DARZALEX (daratumumab) for injection.

For DARZALEX (daratumumab) for injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

More good news for Janssen’s Darzalex For More Details

CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur